TransMedics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
TransMedics Group (Nasdaq: TMDX), a medical technology company specializing in organ transplant therapy solutions, has announced its participation in the 43rd Annual J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
TransMedics Group (Nasdaq: TMDX), a medical technology company specializing in organ transplant therapy solutions, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. The company's management team will deliver a presentation on Monday, January 13, 2025, at 2:15 p.m. PST (5:15 p.m. EST).
TransMedics, which focuses on transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, will make the presentation available through a live and archived webcast on their investor relations website. Interested parties can access both the presentation and the company's standard investor presentation at https://investors.transmedics.com/.
Details
News Market Reaction – TMDX
The recorded move for TMDX in the trading session of this news was +2.00%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Event: 43rd Annual J.P. Morgan Healthcare Conference
Date: Monday, January 13, 2025
Time: 2:15 p.m. PST
A live and archived webcast of the presentation will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/. The Company's standard investor presentation is also available through this link.
About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in
Investor Contact:
Brian Johnston
Laine Morgan
332-895-3222
Investors@transmedics.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-participate-in-the-43rd-annual-jp-morgan-healthcare-conference-302338418.html
SOURCE TransMedics Group, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.